Berkeley Lights, Inc., a cell biology company, operates in enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products in North America, the Asia Pacific, and Europe. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2023-05-08 |
2023-03 |
-0.27 |
N/A |
N/A |
N/A |
2023-02-23 |
2022-12 |
-0.24 |
N/A |
N/A |
N/A |
2022-11-08 |
2022-09 |
-0.27 |
N/A |
N/A |
N/A |
2022-08-09 |
2022-06 |
-0.3 |
N/A |
N/A |
N/A |
2022-05-09 |
2022-03 |
-0.31 |
N/A |
N/A |
N/A |
2022-02-24 |
2021-12 |
-0.25 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2022-08-10 |
Morgan Stanley |
Downgrade |
Equal-Weight |
Underweight |
2022-08-10 |
BTIG |
Downgrade |
Buy |
Neutral |
2022-08-10 |
JP Morgan |
Downgrade |
Overweight |
Neutral |
2022-05-10 |
Morgan Stanley |
Upgrade |
|
Equal-Weight |
2022-02-25 |
Morgan Stanley |
Upgrade |
|
Equal-Weight |
2022-02-15 |
Morgan Stanley |
Upgrade |
|
Equal-Weight |
Date |
Name |
Relation |
Quantity |
Description |
2022-09-15 |
BREINLINGER KEITH J. |
Chief Technology Officer |
157.44K |
Conversion of Exercise of derivative security |
2022-09-18 |
CHAPLIN SCOTT DAVID |
Officer |
227.96K |
Stock Award(Grant) |
2023-03-02 |
JOSHI MEHUL |
Chief Financial Officer |
516.94K |
Stock Award(Grant) |
2023-03-02 |
KADIA SIDDHARTHA |
Chief Executive Officer |
1.24M |
Stock Award(Grant) |
2022-05-25 |
KHANDROS IGOR Y |
Director and Beneficial Owner of more than 10% of a Class of Security |
9.01M |
Stock Award(Grant) |
2022-05-25 |
LUCIER GREGORY T |
Director |
0.00 |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2022-12-30 |
Blackrock Inc. |
4.64M |
5.57M |
6.44% |
2022-12-30 |
Mackenzie Financial Corporation |
4.17M |
5.00M |
5.78% |
2022-12-30 |
Vanguard Group, Inc. (The) |
3.21M |
3.85M |
4.45% |
2022-12-30 |
Nierenberg Investment Management Company, Inc. |
3.16M |
3.79M |
4.37% |
2022-12-30 |
ARK Investment Management, LLC |
2.76M |
3.31M |
3.83% |
2022-12-30 |
Glenview Capital Management, Llc |
2.61M |
3.13M |
3.62% |
Report Date |
Organization |
Position |
Value |
Percentage |
2022-12-30 |
ARK ETF Tr-ARK Genomic Revolution ETF |
2.74M |
3.28M |
3.79% |
2022-09-29 |
Vanguard Total Stock Market Index Fund |
1.84M |
2.21M |
2.56% |
2022-12-30 |
iShares Russell 2000 ETF |
1.25M |
1.50M |
1.74% |
2022-10-30 |
Federated Hermes MDT Small Cap Core Fund |
1.21M |
1.45M |
1.68% |
2022-09-29 |
Vanguard Extended Market Index Fund |
935.23K |
1.12M |
1.30% |
2022-10-30 |
Federated Hermes MDT Mid Cap Growth Fund |
896.43K |
1.08M |
1.24% |